Evogene (EVGN) — Cash Flow-to-Debt Ratio

Latest as of September 2025: -0.43x

Evogene (EVGN) has a Cash Flow-to-Debt Ratio of -0.43x as of September 2025, meaning its operating cash flow of ILA-3.79 Million could theoretically repay 0% of its total liabilities (ILA8.83 Million) in one year. Explore EVGN long-term investments to assets to see how much of total assets are deployed in long-term investments.

CF-to-Debt Ratio

-0.43x
Operating CF / Total Liabilities

Operating Cash Flow

ILA-3.79 Million
ILA

Total Liabilities

ILA8.83 Million
ILA

Data as of

Sep 2025
Most recent filing

Evogene Cash Flow-to-Debt Ratio (2008–2024)

Historical debt coverage capacity for Evogene across 16 annual periods. Also explore Evogene assets under control for the complete picture of this company's asset base.

Annual Cash Flow-to-Debt Ratio for Evogene (2008–2024)

Year-by-year debt coverage analysis for Evogene. For market capitalisation and broader financial context, see EVGN company net worth.

Year CF-to-Debt Ratio Operating CF (ILA) Total Liabilities YoY Change
2024 -0.79x ILA-19.70 Million ILA25.03 Million ▲ +18.2%
2023 -0.96x ILA-21.58 Million ILA22.42 Million ▲ +13.3%
2022 -1.11x ILA-23.68 Million ILA21.34 Million ▲ +42.4%
2021 -1.93x ILA-24.84 Million ILA12.88 Million ▼ -48.5%
2020 -1.30x ILA-19.51 Million ILA15.03 Million ▲ +16.7%
2019 -1.56x ILA-17.36 Million ILA11.15 Million ▲ +13.8%
2018 -1.81x ILA-15.16 Million ILA8.39 Million ▲ +6.7%
2017 -1.94x ILA-15.93 Million ILA8.22 Million ▼ -44.1%
2016 -1.34x ILA-11.69 Million ILA8.70 Million ▲ +4.2%
2015 -1.40x ILA-12.41 Million ILA8.84 Million ▼ -81.5%
2014 -0.77x ILA-8.89 Million ILA11.50 Million ▼ -84.3%
2013 -0.42x ILA-5.27 Million ILA12.56 Million ▼ -268.7%
2012 -0.11x ILA-1.89 Million ILA16.60 Million ▼ -205.6%
2011 0.11x ILA2.13 Million ILA19.80 Million ▲ +186.2%
2009 0.04x ILA886.00K ILA23.54 Million ▼ -92.7%
2008 0.52x ILA12.61 Million ILA24.34 Million
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.